GlassScriptPhysician profile
Haley Ann Evans
NPI 1396388997
$1,254.39
in general payments reported to CMS, 2019-2025
21 companies · $344 in 2025
The $344 reported for 2025 was more than what 78% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $244 · 2023: $457 · 2024: $209 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,010.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,009.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $247.79 | 2023-2025 | |
| Exeltis, USA INC. | $198.01 | 2022-2025 | Slynd |
| Shield Therapeutics INC | $104.08 | 2023-2025 | Accrufer |
| Millicent US INC | $92.08 | 2023-2025 | Intrarosa, Femlyv, Femring |
| Bayer Healthcare Pharmaceuticals INC. | $84.21 | 2023-2025 | |
| Siemens Medical Solutions USA, INC. | $52.44 | 2022-2025 | Varian Cryocare Touch System, Microthermx Microwave Ablation System |
| Abbvie INC. | $49.96 | 2023 | |
| Scynexis, INC. | $49.30 | 2022 | |
| Evofem Biosciences, INC. | $46.42 | 2022-2023 | Phexxi |
| Sumitomo Pharma America, INC. | $46.04 | 2023-2025 | Myfembree |
| Sage Therapeutics, LLC | $44.98 | 2024-2025 | Zurzuvae |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $40.80 | 2024 | Cabtreo |
| Biohaven Pharmaceutical Holding Company LTD. | $40.42 | 2022 | |
| Pfizer INC. | $38.50 | 2023-2024 | |
| Helsinn Therapeutics (U.S.), INC. | $21.06 | 2024 | Valchlor |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $19.28 | 2024 | Rexulti |
| Astellas Pharma US INC | $18.84 | 2025 | Veozah |
| Exact Sciences Corporation | $17.98 | 2023 | Cologuard Collection Kit |
| Supernus Pharmaceuticals, INC. | $15.76 | 2025 | Qelbree |
| Novo Nordisk INC | $13.90 | 2023 | |
| Therapeuticsmd, INC. | $12.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.